Volume 9, Issue 2 (2023)                   IEM 2023, 9(2): 99-106 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Delroshan N, Ghandehari F, Mirzaei R, Hoveida L. Molecular Typing of Multidrug-Resistant Pseudomonas aeruginosa Isolates Obtained from Hospitalized Burn Patients by Rep-PCR. IEM 2023; 9 (2) :99-106
URL: http://iem.modares.ac.ir/article-4-66033-en.html
1- Department of Microbiology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
2- Department of Microbiology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran , La.hoveida@iau.ac.ir
Abstract:   (369 Views)
Backgrounds: Multidrug-resistant Pseudomonas aeruginosa is known as a major opportunistic pathogen in burn patients with hospital-acquired infections. The aim of this study was to investigate antibiotic resistance and the capability of (GTG) 5-PCR (polymerase chain reaction) assay for molecular typing of P. aeruginosa strains isolated from clinical samples of hospitalized burn patients in southern Iran.
Materials & Methods: This cross-sectional research was carried out on 70 P. aeruginosa isolates collected from hospitalized burn patients in southern Iran from June 2020 to January 2021. Antimicrobial susceptibility patterns of the isolates were determined using disk diffusion method. Additionally, repetitive extragenic palindromic-PCR (rep-PCR) method was used to examine the genetic similarities among the strains.
Findings: Antimicrobial susceptibility patterns revealed that the highest antibiotic resistance was against gentamicin (95.8%), followed by imipenem (94.3%) and piperacillin–tazobactam (92.8%), while colistin was the most effective antimicrobial agent. Rep-PCR typing revealed that 60 P. aeruginosa strains were classified into 49 GTG5 types (G1-G49), which were then grouped into 12 clusters (A-L) and 10 isolates with unique banding patterns according to the 80% cut off point.
Conclusion: The present study data indicated a substantial resistance to the studied antimicrobial agents, especially the last-resort antimicrobial agents. In addition, rep-PCR analysis revealed that most of the evaluated strains had partial genetic diversity; therefore, infection control activities should be carried out to decrease the colonization of MDR P. aeruginosa isolates in the hospital setting.
Full-Text [PDF 656 kb]   (181 Downloads)    
Article Type: Original Research | Subject: Bacteriology
Received: 2022/12/13 | Accepted: 2023/06/3 | Published: 2023/08/19

References
1. Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect. 2005;11(Suppl 4):17-32. [DOI:10.1111/j.1469-0691.2005.01161.x] [PMID]
2. Moradali MF, Ghods S, Rehm BH. Pseudomonas aeruginosa lifestyle: A paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol. 2017;7:39. [DOI:10.3389/fcimb.2017.00039] [PMID] []
3. Karlowsky JA, Jones ME, Thornsberry C, Evangelista AT, Yee YC, Sahm DF. Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies. Clin Infect Dis. 2005;40(Suppl 2):S89-98. [DOI:10.1086/426188]
4. Brzozowski M, Krukowska Ż, Galant K, Jursa-Kulesza J, Kosik-Bogacka D. Genotypic characterisation and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients of different hospitals and medical centres in Poland. BMC Infect Dis. 2020;20(1):1-9. [DOI:10.1186/s12879-020-05404-w] [PMID] []
5. Foumani AA, Kalurazi TY, Rostami FM, Ebrahim-Saraie HS, Nazari-Alam A, Halaji M. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis patients in Iran: A systematic review and meta-analysis. Infez Med. 2020;28(3):314-21.
6. Strateva T, Yordanov D. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol. 2009;58(9):1133-48. [DOI:10.1099/jmm.0.009142-0] [PMID]
7. Parsa P, Amirmozafari N, Nowruzi B, Bahar MA. Molecular characterization of polymorphisms among Pseudomonas aeruginosa strains isolated from burn patients' wounds. Heliyon. 2020;6(12):e05041. [DOI:10.1016/j.heliyon.2020.e05041] [PMID] []
8. Sorkh MA, Shokoohizadeh L, Rashidi N, Tajbakhsh E. Molecular analysis of Pseudomonas aeruginosa strains isolated from burn patients by repetitive extragenic palindromic-PCR (rep-PCR). Iran Red Crescent Med J. 2017;19(4):e43508. [DOI:10.5812/ircmj.43508]
9. Heidari H, Halaji M, Taji A, Kazemian H, Abadi MS, Taheripour Sisakht M, et al. Molecular analysis of drug-resistant Acinetobacter baumannii isolates by ERIC-PCR. Meta Gene. 2018;17:132-5. [DOI:10.1016/j.mgene.2018.06.001]
10. Faridi F, Javadpour S. REP-PCR typing, antibiogram pattern, and distribution of clinical isolates of Pseudomonas aeruginosa in a teaching hospital in south of Iran. Mol Med J. 2015;1(1):47-55.
11. Faghri J, Nouri S, Jalalifar S, Zalipoor M, Halaji M. Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran. BMC Res Notes. 2018;11(1):1-5. [DOI:10.1186/s13104-018-3901-9] [PMID] []
12. Clinical and Laboratory Standards Institute. M100-S30: Performance standards for antimicrobial susceptibility testing; 24th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
13. Halaji M, Shahidi S, Atapour A, Ataei B, Feizi A, Havaei SA. Characterization of extended-spectrum β-lactamase-producing uropathogenic Escherichia coli among Iranian kidney transplant patients. Infect Drug Resist. 2020;13:1429-37. [DOI:10.2147/IDR.S248572] []
14. Rashno Taee S, Khansarinejad B, Abtahi H, Najafimosleh M, Ghaznavi-Rad E. Detection of algD, oprL and exoA genes by new specific primers as an efficient, rapid, and accurate procedure for direct diagnosis of Pseudomonas aeruginosa strains in clinical samples. Jundishapur J Microbiol. 2014;7(10):e13583. [DOI:10.5812/jjm.13583] [PMID] []
15. Raman G, Avendano EE, Chan J, Merchant S, Puzniak L. Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: A systematic review and meta-analysis. Antimicrob Resist Infect Control. 2018;7:1-4. [DOI:10.1186/s13756-018-0370-9] [PMID] []
16. Nikbin VS, Aslani MM, Sharafi Z, Hashemipour M, Shahcheraghi F, Ebrahimipour GH. Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins. Iran J Microbiol. 2012;4(3):118-23.
17. Khan AA, Cerniglia CE. Detection of Pseudomonas aeruginosa from clinical and environmental samples by amplification of the exotoxin A gene using PCR. Appl Environ Microbiol. 1994;60(10):3739-45. [DOI:10.1128/aem.60.10.3739-3745.1994] [PMID] []
18. Ranjbar R, Owlia P, Saderi H, Mansouri S, Jonaidi-Jafari N, Izadi M, et al. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran. Acta Med Iran. 2011;49(10):675-9.
19. Khosravi AD, Motahar M, Abbasi Montazeri E. The frequency of class 1 and 2 integrons in Pseudomonas aeruginosa strains isolated from burn patients in a burn center of Ahvaz, Iran. PLoS One. 2017;12(8):e0183061. [DOI:10.1371/journal.pone.0183061] [PMID] []
20. Mobaraki S, Aghazadeh M, Barhaghi MH, Memar MY, Goli HR, Gholizadeh P, et al. Prevalence of integrons 1, 2, 3 associated with antibiotic resistance in Pseudomonas aeruginosa isolates from northwest of Iran. Biomedicine. 2018;8(1):2. [DOI:10.1051/bmdcn/2018080102] [PMID] []
21. Goli HR, Nahaei MR, Rezaee MA, Hasani A, Kafil HS, Aghazadeh M, et al. Prevalence and molecular characterization of class 1 integrons among clinical isolates of Pseudomonas aeruginosa in northwest of Iran. Mol Genet Microbiol Virol. 2017;32(2):109-15. [DOI:10.3103/S0891416817020057]
22. Fazeli H, Solgi H, Havaei SA, Shokri D, Norouzi Barogh M, Zamani FZ. Carbapenem and fluoroquinolone resistance in multidrug resistant Pseudomonas aeruginosa isolates from Al-Zahra hospital, Isfahan, Iran. J Med Microbiol Infect Dis. 2014;2(4):147-52.
23. Kashfi M, Hashemi A, Eslami G, Sadredin Amin M, Tarashi S, Taki E. The prevalence of aminoglycoside-modifying enzyme genes among Pseudomonas aeruginosa strains isolated from burn patients. Arch Clin Infect Dis. 2017;12(1):e40896. [DOI:10.5812/archcid.40896]
24. Banar M, Emaneini M, Satarzadeh M, Abdellahi N, Beigverdi R, Leeuwen WB, et al. Evaluation of mannosidase and trypsin enzymes effects on biofilm production of Pseudomonas aeruginosa isolated from burn wound infections. PLoS One. 2016;11(10):e0164622. [DOI:10.1371/journal.pone.0164622] [PMID] []
25. Zarei-Yazdeli M, Eslami G, Zandi H, Kiani M, Barzegar K, Alipanah H, et al. Prevalence of class 1, 2, and 3 integrons among multidrug-resistant Pseudomonas aeruginosa in Yazd, Iran. Iran J Microbiol. 2018;10(5):300-6.
26. Coetzee E, Rode H, Kahn D. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit. S Afr J Surg. 2013;51(2):50-3. [DOI:10.7196/sajs.1134] [PMID]
27. Singh NP, Goyal R, Manchanda V, Das S, Kaur I, Talwar V. Changing trends in bacteriology of burns in the burns unit, Delhi, India. Burns. 2003;29(2):129-32. [DOI:10.1016/S0305-4179(02)00249-8] [PMID]
28. Song W, Lee KM, Kang HJ, Shin DH, Kim DK. Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea. Burns. 2001;27(2):136-9. [DOI:10.1016/S0305-4179(00)00086-3]
29. Vaez H, Salehi-Abargouei A, Ghalehnoo ZR, Khademi F. Multidrug resistant Pseudomonas aeruginosa in Iran: A systematic review and meta-analysis. J Glob Infect Dis. 2018;10(4):212-7. [DOI:10.4103/jgid.jgid_113_17] [PMID] []
30. Tarafdar F, Jafari B, Azimi T. Evaluating the antimicrobial resistance patterns and molecular frequency of bla (oxa-48) and bla (GES-2) genes in Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from burn wound infection in Tehran, Iran. New Microbes New Infect. 2020;37:100686. [DOI:10.1016/j.nmni.2020.100686] [PMID] []
31. Khan F, Khan A, Kazmi SU. Prevalence and susceptibility pattern of multi-drug resistant clinical isolates of Pseudomonas aeruginosa in Karachi. Pak J Med Sci. 2014;30(5):951-4. [DOI:10.12669/pjms.305.5400] [PMID] []
32. Mirzaei B, Bazgir ZN, Goli HR, Iranpour F, Mohammadi F, Babaei R. Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from northeast of Iran. BMC Res Notes. 2020;13(1):1-6. [DOI:10.1186/s13104-020-05224-w] [PMID] []
33. Doléans-Jordheim A, Cournoyer B, Bergeron E, Croizé J, Salord H, André J, et al. Reliability of Pseudomonas aeruginosa semi-automated rep-PCR genotyping in various epidemiological situations. Eur J Clin Microbiol Infect Dis. 2009;28(9):1105-11. [DOI:10.1007/s10096-009-0755-z] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.